The Seattle Translational Tumor Research (STTR), formerly Solid Tumor Translational Research, is a multidisciplinary and multi-organizational effort of physicians and scientists from Fred Hutch, UW Medicine and Seattle Cancer Care Alliance. The primary goal is to translate laboratory sciences into the most precise treatment options for patients with solid tumor cancers.
Together these leading cancer research and clinical care organizations are enhancing our knowledge of cancer using population research, preclinical cancer biology, translational, imaging and clinical studies of solid tumors.
Fred Hutch, world renowned for its research and treatment of cancers of the blood, has committed to increasing the ongoing research on solid tumor cancer biology that is being done in the Basic Sciences, Human Biology and Clinical Research divisions, as well as the excellent population-based research on solid tumors done in the Public Health Sciences Division. The goal is to translate this focused commitment to advances in solid tumor treatment.
Revolutionizing solid tumor cancer treatment
Launched by Dr. Eric Holland, the STTR sets the stage for collaborations where scientists share insights into how to improve treatment for many tumors, leading to discoveries that can be applied to cancer. It’s the best shot at making headway against the disease.
Starting with brain, Holland is building a database based on thousands of tumor samples from patients. The database will contain complete genetics profiles for each tumor, plus information on how each patient was treated and responded. Eventually the database will be expanded to breast, colon, head and neck, lung, ovarian, pancreas and prostate. The goal is to profile tumors for every patient which can be compared to those in the database and inform the decision on the most effective therapy.
"This is personalized medicine - making decisions that are tailored to the tumor," Holland said.
In order to reveal the patterns buried in reams of data, Holland and his colleagues in STTR spearheaded the development of Oncoscape, an online data visualization tool. Oncoscape is designed to be modular, so new applications with specific functions can be easily integrated and contribute new functionality to the collection of existing apps.
2017 Overview - Speeding Cancer Research and Improving Clinical Care
A web-based data exploration and visualization portal
Oncoscape is designed to create a collaborative platform and community that unites the clinical, genetic, and computational fields in an effort to advance the understanding of cancer biology and improve patient care. Our goal is to equip researchers with the necessary tools and resources to discover, develop and implement first class treatment strategies to revolutionize personalized patient care.
This event is an opportunity to thank the entire oncology community (Fred Hutch, UW Medicine, and Seattle Cancer Care Alliance for their work in cancer care, detection, prevention, research, innovation and support roles. Nominate and employee or submit an improvement >
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.